NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 220 filers reported holding NOVAVAX INC in Q2 2023. The put-call ratio across all filers is 1.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $99,099 | -53.3% | 14,300 | +793.8% | 0.00% | -97.4% |
| Q3 2022 | $212,000 | -69.8% | 1,600 | -90.5% | 0.12% | +69.1% |
| Q4 2021 | $702,000 | +153.4% | 16,799 | +71.4% | 0.07% | -46.9% |
| Q3 2021 | $277,000 | +0.4% | 9,800 | +48.5% | 0.13% | +6.7% |
| Q2 2021 | $276,000 | -35.5% | 6,600 | +179.3% | 0.12% | +400.0% |
| Q1 2021 | $428,000 | +15.4% | 2,363 | -29.0% | 0.02% | -7.7% |
| Q4 2020 | $371,000 | -7.5% | 3,329 | -10.0% | 0.03% | -21.2% |
| Q3 2020 | $401,000 | – | 3,699 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 3,002,087 | $544,308,000 | 8.21% |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 323,517 | $58,657,000 | 7.86% |
| Samsara BioCapital, LLC | 198,600 | $36,008,000 | 6.64% |
| Foresite Capital Management I, LLC | 66,810 | $12,113,000 | 6.11% |
| Foresite Capital Management II, LLC | 67,373 | $12,215,000 | 2.81% |
| SECTORAL ASSET MANAGEMENT INC | 191,200 | $34,666,000 | 2.63% |
| Rock Springs Capital Management LP | 461,000 | $83,584,000 | 1.82% |
| TSP Capital Management Group, LLC | 23,525 | $4,265,000 | 1.50% |
| Ikarian Capital, LLC | 195,700 | $35,483,000 | 1.19% |
| SevenOneSeven Capital Management | 1,744 | $316,000 | 1.16% |